Key neurochemical markers for the prevention of suicide

S Slater, MM Villalba, J Davis

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Suicide is an ever-present concern in healthcare provision and, with over 1 million fatalities attributed to this cause each year, it is a problem that is continually in need of a solution. A key issue is identification of those individuals at risk so that effective interventions can be employed.There are significant differences in the neurochemical picture of those suffering from suicidal ideation and normal individuals. Analytical techniques have been widely used to elucidate the pathways involved in the neurochemistry of depression and suicide with the aim of developing more effective treatments. However, there is a clear opportunity for exploiting the advances made in those previous investigations as the foundation for the development of screening assays that, through measuring the variations in neurochemical composition, could offer a more objective assessment of suicide risk.We give an overview of the various species involved in suicidal behaviour and their significance to risk assessment. Moreover, we provide a critical evaluation of the analytical strategies associated with the measurement of those biomarkers and the potential for transferring the technology from pure research to the development of more routine systems for clinical screening
    LanguageEnglish
    Pages1037-1047
    JournalTrends in Analytical Chemistry
    Volume28
    Issue number9
    DOIs
    Publication statusPublished - Oct 2009

    Fingerprint

    Screening
    Biomarkers
    Risk assessment
    Assays
    Chemical analysis
    Neurochemistry

    Keywords

    • Biomarker
    • Chromatography
    • Clinical screening
    • Dopamine
    • Neurochemistry
    • Prevention of suicide
    • Screening assay
    • Serotonin
    • Suicidal ideation
    • Suicide

    Cite this

    Slater, S ; Villalba, MM ; Davis, J. / Key neurochemical markers for the prevention of suicide. 2009 ; Vol. 28, No. 9. pp. 1037-1047.
    @article{2761921d8cf3486ea16057517a2d8085,
    title = "Key neurochemical markers for the prevention of suicide",
    abstract = "Suicide is an ever-present concern in healthcare provision and, with over 1 million fatalities attributed to this cause each year, it is a problem that is continually in need of a solution. A key issue is identification of those individuals at risk so that effective interventions can be employed.There are significant differences in the neurochemical picture of those suffering from suicidal ideation and normal individuals. Analytical techniques have been widely used to elucidate the pathways involved in the neurochemistry of depression and suicide with the aim of developing more effective treatments. However, there is a clear opportunity for exploiting the advances made in those previous investigations as the foundation for the development of screening assays that, through measuring the variations in neurochemical composition, could offer a more objective assessment of suicide risk.We give an overview of the various species involved in suicidal behaviour and their significance to risk assessment. Moreover, we provide a critical evaluation of the analytical strategies associated with the measurement of those biomarkers and the potential for transferring the technology from pure research to the development of more routine systems for clinical screening",
    keywords = "Biomarker, Chromatography, Clinical screening, Dopamine, Neurochemistry, Prevention of suicide, Screening assay, Serotonin, Suicidal ideation, Suicide",
    author = "S Slater and MM Villalba and J Davis",
    year = "2009",
    month = "10",
    doi = "10.1016/j.trac.2009.06.002",
    language = "English",
    volume = "28",
    pages = "1037--1047",
    number = "9",

    }

    Key neurochemical markers for the prevention of suicide. / Slater, S; Villalba, MM; Davis, J.

    Vol. 28, No. 9, 10.2009, p. 1037-1047.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Key neurochemical markers for the prevention of suicide

    AU - Slater, S

    AU - Villalba, MM

    AU - Davis, J

    PY - 2009/10

    Y1 - 2009/10

    N2 - Suicide is an ever-present concern in healthcare provision and, with over 1 million fatalities attributed to this cause each year, it is a problem that is continually in need of a solution. A key issue is identification of those individuals at risk so that effective interventions can be employed.There are significant differences in the neurochemical picture of those suffering from suicidal ideation and normal individuals. Analytical techniques have been widely used to elucidate the pathways involved in the neurochemistry of depression and suicide with the aim of developing more effective treatments. However, there is a clear opportunity for exploiting the advances made in those previous investigations as the foundation for the development of screening assays that, through measuring the variations in neurochemical composition, could offer a more objective assessment of suicide risk.We give an overview of the various species involved in suicidal behaviour and their significance to risk assessment. Moreover, we provide a critical evaluation of the analytical strategies associated with the measurement of those biomarkers and the potential for transferring the technology from pure research to the development of more routine systems for clinical screening

    AB - Suicide is an ever-present concern in healthcare provision and, with over 1 million fatalities attributed to this cause each year, it is a problem that is continually in need of a solution. A key issue is identification of those individuals at risk so that effective interventions can be employed.There are significant differences in the neurochemical picture of those suffering from suicidal ideation and normal individuals. Analytical techniques have been widely used to elucidate the pathways involved in the neurochemistry of depression and suicide with the aim of developing more effective treatments. However, there is a clear opportunity for exploiting the advances made in those previous investigations as the foundation for the development of screening assays that, through measuring the variations in neurochemical composition, could offer a more objective assessment of suicide risk.We give an overview of the various species involved in suicidal behaviour and their significance to risk assessment. Moreover, we provide a critical evaluation of the analytical strategies associated with the measurement of those biomarkers and the potential for transferring the technology from pure research to the development of more routine systems for clinical screening

    KW - Biomarker

    KW - Chromatography

    KW - Clinical screening

    KW - Dopamine

    KW - Neurochemistry

    KW - Prevention of suicide

    KW - Screening assay

    KW - Serotonin

    KW - Suicidal ideation

    KW - Suicide

    U2 - 10.1016/j.trac.2009.06.002

    DO - 10.1016/j.trac.2009.06.002

    M3 - Article

    VL - 28

    SP - 1037

    EP - 1047

    IS - 9

    ER -